Christopher W. Rowe

578 total citations
35 papers, 359 citations indexed

About

Christopher W. Rowe is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Epidemiology. According to data from OpenAlex, Christopher W. Rowe has authored 35 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 7 papers in General Health Professions and 7 papers in Epidemiology. Recurrent topics in Christopher W. Rowe's work include Thyroid Cancer Diagnosis and Treatment (19 papers), Neuroendocrine Tumor Research Advances (6 papers) and Patient-Provider Communication in Healthcare (6 papers). Christopher W. Rowe is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (19 papers), Neuroendocrine Tumor Research Advances (6 papers) and Patient-Provider Communication in Healthcare (6 papers). Christopher W. Rowe collaborates with scholars based in Australia and United Kingdom. Christopher W. Rowe's co-authors include Sam Faulkner, Hubert Hondermarck, Roger Smith, Shaun McGrath, Jonathan Paúl, Nathan Griffin, Marjorie M. Walker, Cino Bendinelli, Katie Wynne and Christine J. O’Neill and has published in prestigious journals such as Diabetes Care, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Christopher W. Rowe

29 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher W. Rowe Australia 11 157 69 66 65 64 35 359
Deborah A. Silverman United States 6 81 0.5× 95 1.4× 82 1.2× 74 1.1× 27 0.4× 10 293
Jialiang Hui China 13 32 0.2× 36 0.5× 115 1.7× 62 1.0× 64 1.0× 30 400
Michelle Roytman United States 13 68 0.4× 29 0.4× 60 0.9× 44 0.7× 114 1.8× 41 545
George Katsamakis United States 5 61 0.4× 81 1.2× 95 1.4× 69 1.1× 16 0.3× 7 465
Zuoxu Fan China 12 34 0.2× 69 1.0× 69 1.0× 17 0.3× 31 0.5× 15 421
Jennifer Beach United States 12 38 0.2× 53 0.8× 80 1.2× 103 1.6× 79 1.2× 21 725
Anja Lisbeth Frederiksen Denmark 14 199 1.3× 23 0.3× 233 3.5× 82 1.3× 81 1.3× 46 552
Kang‐Moon Song South Korea 19 267 1.7× 464 6.7× 218 3.3× 44 0.7× 120 1.9× 45 750
A. Cilotti Italy 11 332 2.1× 175 2.5× 76 1.2× 33 0.5× 190 3.0× 19 599
Gianluca Tamagno Italy 10 258 1.6× 30 0.4× 90 1.4× 26 0.4× 153 2.4× 21 453

Countries citing papers authored by Christopher W. Rowe

Since Specialization
Citations

This map shows the geographic impact of Christopher W. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Rowe more than expected).

Fields of papers citing papers by Christopher W. Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Rowe. The network helps show where Christopher W. Rowe may publish in the future.

Co-authorship network of co-authors of Christopher W. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher W. Rowe. A scholar is included among the top collaborators of Christopher W. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher W. Rowe. Christopher W. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowe, Christopher W., et al.. (2025). FNA of Thyroid Nodules—Clinical Decision-Making in the ACR-TIRADS Era. Clinical Thyroidology. 37(12). 444–448.
2.
Rowe, Christopher W., et al.. (2025). Can Statins Prevent Graves’ Orbitopathy? The Indirect Evidence Accumulates. Clinical Thyroidology. 37(4). 137–139.
3.
4.
O’Neill, Christine J., Christopher W. Rowe, Sarah Leask, et al.. (2025). Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery. Thyroid. 35(9). 1039–1051.
5.
Rowe, Christopher W., et al.. (2024). Will thyroid Lobectomy Become the Most Performed Thyroid Cancer Operation? Should It?. Clinical Thyroidology. 36(9). 326–328.
6.
Zdenkowski, Nicholas, et al.. (2024). Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review. Thyroid. 34(5). 541–558. 8 indexed citations
7.
Wadsley, Jonathan, Sabapathy P. Balasubramanian, Gitta Madani, et al.. (2023). Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancers. Clinical Endocrinology. 101(5). 557–561. 5 indexed citations
8.
O’Neill, Christine J., et al.. (2023). Thyroid cancer patient reported outcome measures in clinical practice: analysing acceptability and optimizing recruitment. ANZ Journal of Surgery. 93(9). 2214–2221. 4 indexed citations
9.
Rowe, Christopher W., Christopher Oldmeadow, Ray Cope, et al.. (2023). Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians. Endocrinology Diabetes & Metabolism. 6(2). e398–e398. 2 indexed citations
10.
11.
12.
Welsh, James S., et al.. (2022). Objective quantification of nerves in immunohistochemistry specimens of thyroid cancer utilising deep learning. PLoS Computational Biology. 18(2). e1009912–e1009912. 1 indexed citations
13.
Navani, Vishal, James Lynam, Steven G. Smith, Christine J. O’Neill, & Christopher W. Rowe. (2021). Castration failure in prostate carcinoma due to a functioning adrenocortical carcinoma. Endocrinology Diabetes and Metabolism Case Reports. 2021. 1 indexed citations
14.
McGrath, Shaun, et al.. (2021). Thyroid disease: Using diagnostic tools effectively. Australian Journal of General Practice. 50(1-2). 16–21. 11 indexed citations
15.
Griffin, Nathan, Christopher W. Rowe, Fangfang Gao, et al.. (2020). Clinicopathological Significance of Nerves in Esophageal Cancer. American Journal Of Pathology. 190(9). 1921–1930. 14 indexed citations
16.
Rowe, Christopher W., Sam Faulkner, Jonathan Paúl, et al.. (2019). The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis. BMC Endocrine Disorders. 19(1). 128–128. 2 indexed citations
17.
Gao, Fangfang, Nathan Griffin, Sam Faulkner, et al.. (2018). The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung. Scientific Reports. 8(1). 8135–8135. 34 indexed citations
18.
Rowe, Christopher W., Ali S. Haider, Deepa Viswanathan, et al.. (2017). Insulin resistance correlates with maculopathy and severity of retinopathy in young adults with Type 1 Diabetes Mellitus. Diabetes Research and Clinical Practice. 131. 154–160. 8 indexed citations
19.
Faulkner, Sam, Christopher W. Rowe, Sonia M. Rodrigues Oliveira, et al.. (2017). Neurotrophin Receptors TrkA, p75NTR, and Sortilin Are Increased and Targetable in Thyroid Cancer. American Journal Of Pathology. 188(1). 229–241. 42 indexed citations
20.
Rowe, Christopher W., Jonathan Paúl, Craig Gedye, et al.. (2017). Targeting the TSH receptor in thyroid cancer. Endocrine Related Cancer. 24(6). R191–R202. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah A. Silverman Breakdown of academic impact, for papers by Jialiang Hui Breakdown of academic impact, for papers by Michelle Roytman Breakdown of academic impact, for papers by George Katsamakis Breakdown of academic impact, for papers by Zuoxu Fan Breakdown of academic impact, for papers by Jennifer Beach Breakdown of academic impact, for papers by Anja Lisbeth Frederiksen Breakdown of academic impact, for papers by Kang‐Moon Song Breakdown of academic impact, for papers by A. Cilotti Breakdown of academic impact, for papers by Gianluca Tamagno
Rankless by CCL
2026